Case number | IFAT | Blood | Lymph-node | Lymph-node in-vitro culture | Conjunctival swab | Oral swab | DTH | DTH |
---|---|---|---|---|---|---|---|---|
 |  | PCR ( Leishmania/mL) | PCR ( Leishmania/sample) |  |  | PCR ( Leishmania/sample) | 48 h (cm) | 72 h (cm) |
 |  |  |  |  | PCR ( Leishmania/sample) |  |  |  |
1 | - | - | - | NP | NP | NP | 2,50# | 1,75# |
2 | - | - | - | - | NP | NP | NP | NP |
3 | - | - | - | - | NP | NP | 3,00# | 3,25# |
4 | - | - | - | NP | - | NP | 1,60# | 1,75# |
5 | 1:80 | - | - | - | + (5) | - | 2,25* | 1,15* |
6 | - | - | - | - | + (10) | - | 1,25* | 2,00* |
7 | - | - | - | - | - | - | NP | NP |
8 | - | - | - | - | + (70) | + (3) | 1,50* | 1,25* |
9 | - | - | - | - | + (20) | - | 1,00* | 0,00* |
10 | - | - | - | - | - | - | 1,50* | 1,75* |
11 | 1:160 | - | - | - | - | - | NP | NP |
12 | - | - | - | NP | - | - | NP | NP |
13 | 1:80 | - | - | NP | NP | NP | NP | NP |
14 | 1:320 | - | - | NP | NP | NP | NP | NP |
15 | 1:320 | - | - | NP | NP | NP | NP | NP |
16 | - | - | + (6) | NP | NP | NP | NP | NP |
17 | - | - | - | NP | NP | NP | NP | NP |
Total number of positive results/total number of dogs studied (%) | 5/17 (29.4%) | 0/17 (0%) | 1/17 (5.8%) | 0/9 (0%) | 4/9 (44.4%) | 1/8 (12.5%) | Â |